TrialAnnals of the rheumatic diseases2017

A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy.

Paul Emery et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.